Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Yolanda Lawson

Obstetrics & Gynecology Dallas, TX Medical Doctor

NPI 1912926312 CMS profile 86511

2509 Thomas Ave, Ste C, Dallas, TX 75201

Open in the dashboard

General payments

$95,776

235 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$53,303 paid to institutions, not to them · program years 2023–2025

Through program year 2025, Yolanda Lawson of Dallas, TX is reported in the CMS Open Payments database as having received $95,776 across 235 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $53,303 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Obstetrics & Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $12,610 23
2024 General $28,358 41
2023 General $30,617 34
2022 General $3,875 40
2021 General $12,401 38
2020 General $6,738 28
2019 General $1,176 31

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Yolanda Lawson
  • Obstetrics & Gynecology median
  • Middle half of Obstetrics & Gynecology
  • National median

In program year 2025, general payments to Yolanda Lawson were reported at $12,610. Among 21,306 Obstetrics & Gynecology profiles paid that year, the median was $158 and the middle half received between $51 and $401.

Show as a table
Year Yolanda Lawson Obstetrics & Gynecology median Middle half National median
2019 $1,176 $172 $62–$391 $163
2020 $6,738 $94 $36–$222 $114
2021 $12,401 $136 $42–$369 $132
2022 $3,875 $160 $50–$433 $149
2023 $30,617 $169 $56–$423 $160
2024 $28,358 $152 $50–$371 $164
2025 $12,610 $158 $51–$401 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. ViiV Healthcare Company $37,177 64 payments
  2. Pfizer Inc. $23,177 13 payments
  3. Gilead Sciences, Inc. $19,539 22 payments
  4. Eisai Inc. $4,247 3 payments
  5. Novartis Pharmaceuticals Corporation $2,479 6 payments
  6. Myovant Sciences Inc. $2,146 7 payments
  7. AbbVie, Inc. $1,818 39 payments
  8. SCYNEXIS, Inc. $1,261 8 payments
  9. AMAG Pharmaceuticals, Inc. $829 4 payments
  10. Coloplast Corp $655 1 payment
  11. Other $2,448 68 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $51,311 21 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $26,020 6 payments
  3. Travel and Lodging $10,176 32 payments
  4. Food and Beverage $7,529 175 payments
  5. Honoraria $740 1 payment
Products named General payments · program years 2019–2025
  1. PAXLOVID $11,964 4 payments
  2. DOVATO $6,705 4 payments
  3. APRETUDE Hiv $5,850 2 payments
  4. Yeztugo $1,860 1 payment
  5. MYFEMBREE $1,525 1 payment
  6. APRETUDE Hiv $975 1 payment
  7. MAKENA $829 4 payments
  8. Sonata System $555 2 payments
  9. ORILISSA Womens Health $555 19 payments
  10. Orilissa Endocrinology $329 12 payments
  11. Other $2,729 94 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

235 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Obstetrics & Gynecology in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record